BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15778580)

  • 21. Application of the linear-quadratic model with incomplete repair to radionuclide directed therapy.
    Millar WT
    Br J Radiol; 1991 Mar; 64(759):242-51. PubMed ID: 2021798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why more needs to be known about RBE effects in modern radiotherapy.
    Dale RG; Jones B; Cárabe-Fernández A
    Appl Radiat Isot; 2009 Mar; 67(3):387-92. PubMed ID: 18701310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer.
    Lennernäs B; Albertsson P; Edgren M; Nilsson S
    Oncol Rep; 2007 Nov; 18(5):1299-303. PubMed ID: 17914588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractionation effects in particle radiotherapy: implications for hypo-fractionation regimes.
    Carabe-Fernandez A; Dale RG; Hopewell JW; Jones B; Paganetti H
    Phys Med Biol; 2010 Oct; 55(19):5685-700. PubMed ID: 20826903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferation and the advantage of longer-lived radionuclides in radioimmunotherapy.
    Howell RW; Goddu SM; Rao DV
    Med Phys; 1998 Jan; 25(1):37-42. PubMed ID: 9472824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calculated LET spectrum from antiproton beams stopping in water.
    Bassler N; Holzscheiter M
    Acta Oncol; 2009; 48(2):223-6. PubMed ID: 18932095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study.
    Guerrero M; Li XA; Earl MA; Sarfaraz M; Kiggundu E
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1513-22. PubMed ID: 15275739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The radiobiology of hypofractionation.
    Nahum AE
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LQ-based model for biological radiotherapy planning.
    Koukourakis MI; Damilakis J
    Med Dosim; 1994; 19(4):269-77. PubMed ID: 7893363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tables of equivalent dose in 2 Gy fractions: a simple application of the linear quadratic formula.
    Barton M
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):371-8. PubMed ID: 7836091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linear quadratic and tumour control probability modelling in external beam radiotherapy.
    O'Rourke SF; McAneney H; Hillen T
    J Math Biol; 2009 Apr; 58(4-5):799-817. PubMed ID: 18825382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
    Park C; Papiez L; Zhang S; Story M; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 1989 James Kirk memorial lecture. The potential for radiobiological modelling in radiotherapy treatment design.
    Dale RG
    Radiother Oncol; 1990 Nov; 19(3):245-55. PubMed ID: 2281154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the linear-quadratic model to combined modality radiotherapy.
    Bodey RK; Evans PM; Flux GD
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):228-41. PubMed ID: 15093920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basic principles of radiobiology applied to radiosurgery and radiotherapy of benign skull base tumors.
    Anker CJ; Shrieve DC
    Otolaryngol Clin North Am; 2009 Aug; 42(4):601-21. PubMed ID: 19751867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotargeting agents for cancer therapy.
    Kassis AI
    Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
    Viola A; Major T; Julow J
    Radiat Res; 2006 Jun; 165(6):695-702. PubMed ID: 16802870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fast multifield optimization of the biological effect in ion therapy.
    Wilkens JJ; Oelfke U
    Phys Med Biol; 2006 Jun; 51(12):3127-40. PubMed ID: 16757867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay.
    Calugaru V; Nauraye C; Noël G; Giocanti N; Favaudon V; Mégnin-Chanet F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1136-43. PubMed ID: 21075549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.